ArticleThe Journal of allergy and clinical immunology2009
IgE-mediated allergen gene vaccine platform targeting human antigen-presenting cells through the high-affinity IgE receptor.
Anne Behnecke et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.